Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocugen (OCGN) Common Equity (2016 - 2025)

Ocugen's Common Equity history spans 12 years, with the latest figure at -$12.2 million for Q4 2025.

  • For Q4 2025, Common Equity fell 141.06% year-over-year to -$12.2 million; the TTM value through Dec 2025 reached -$12.2 million, down 141.06%, while the annual FY2025 figure was -$12.2 million, 141.06% down from the prior year.
  • Common Equity reached -$12.2 million in Q4 2025 per OCGN's latest filing, down from $3.5 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $125.5 million in Q1 2022 to a low of -$12.2 million in Q4 2025.
  • Average Common Equity over 5 years is $54.8 million, with a median of $48.1 million recorded in 2021.
  • Peak YoY movement for Common Equity: skyrocketed 696.07% in 2021, then tumbled 141.06% in 2025.
  • A 5-year view of Common Equity shows it stood at $91.2 million in 2021, then decreased by 18.88% to $74.0 million in 2022, then plummeted by 45.17% to $40.6 million in 2023, then dropped by 26.95% to $29.6 million in 2024, then tumbled by 141.06% to -$12.2 million in 2025.
  • Per Business Quant, the three most recent readings for OCGN's Common Equity are -$12.2 million (Q4 2025), $3.5 million (Q3 2025), and $3.1 million (Q2 2025).